Page last updated: 2024-10-30

lorazepam and Granulomatosis with Polyangiitis

lorazepam has been researched along with Granulomatosis with Polyangiitis in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
West, S1
Kenedi, C1
Hoffman, GS1
Leavitt, RY1
Fleisher, TA1
Minor, JR1
Fauci, AS1

Reviews

1 review available for lorazepam and Granulomatosis with Polyangiitis

ArticleYear
Strategies to prevent the neuropsychiatric side-effects of corticosteroids: a case report and review of the literature.
    Current opinion in organ transplantation, 2014, Volume: 19, Issue:2

    Topics: Adult; Amines; Benzodiazepines; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gaba

2014

Other Studies

1 other study available for lorazepam and Granulomatosis with Polyangiitis

ArticleYear
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    The American journal of medicine, 1990, Volume: 89, Issue:4

    Topics: Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Female; Granulomatosis with Polyangiiti

1990